Immune response to mRNA-based COVID-19 booster vaccination in people living with HIV.

Jakob J Malin Isabelle Suárez Lena M Biehl Philipp Schommers Elena KnopsVeronica Di CristanzianoEva HegerEva PfliegerChristoph Wyen Daniel Bettin Jan Rybniker Gerd Fätkenheuer Clara Lehmann

Published in: HIV medicine (2023)

cells/μL showed favourable immune responses to mRNA-based COVID-19 booster vaccination. A longer time (up to 29 weeks) since second vaccination was associated with higher serological responses, whereas choice of mRNA vaccine or concomitant influenza vaccination had no impact.

Keyphrases

immune response
coronavirus disease
sars cov
binding protein
induced apoptosis